Buscar resultados de ensayos clínicos
Factor XIII Deficiency - 9 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency Condición: Factor XIII Deficiency Fecha: 2009-04-21 Intervenciones: Biological: FXIII Concentrate (Human) Doses will be guided |
Completed |
Nombre del estudio: An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency Condición: Factor XIII Deficiency Fecha: 2009-07-23 Intervenciones: Biological: FXIII Concentrate (Human) (FXIII) Doses will b |
Completed |
Nombre del estudio: A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency Condición: Factor XIII Deficiency Fecha: 2009-04-16 Intervenciones: Biological: FXIII Concentrate (Human) Subjects will receive approximately 40 U/kg of FXIII every 28 days |
Completed |
Nombre del estudio: Clinical Trial of Factor XIII (FXIII) Concentrate Condición:
Fecha: 2008-03-17 Intervenciones: Drug: Fibrogammin P Prophylaxis treatment |
Completed |
Nombre del estudio: Wound Healing Abnormalities in Major Abdominal Surgery Condición:
Fecha: 2008-08-14 |
Completed |
Nombre del estudio: Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725 Condición:
Fecha: 2009-09-15 Intervenciones: Drug: catridecacog Monthly administration of recombinant factor XIII as preventative treatment of bleedi |
Completed |
Nombre del estudio: Factor XIII and Pulmonary Embolism in Neurosurgical Patients Condición:
|
Completed |
Nombre del estudio: Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency Condición:
Fecha: 2003-03-18 Intervenciones: Drug: catridecacog Single doses of rFXIII administered intravenously (IV) to two subjects in each of the |
Completed |
Nombre del estudio: Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency Condición:
Fecha: 2008-07-07 Intervenciones: Drug: catridecacog 35 IU/kg body weight, i.v. administration, once every 4 weeks |